Biomarkers associated with obstructive sleep apnea: A scoping review

Sleep Medicine Reviews

Volumn 23, Issue , 2015, Pages 28-45

  De Luca Canto, Graziela ^a,b   Pachêco Pereira, Camila ^b   Aydinoz, Secil ^c,d   Major, Paul W ^b   Flores Mir, Carlos ^b   Gozal, David ^d,e  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSITY OF ALBERTA   (Canada)

^c GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^d UNIVERSITY OF CHICAGO   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

Author keywords

Biomarker; Diagnoses; Sleep apnea

Indexed keywords

8 ISOPROSTANE; ADIPONECTIN; AMYLASE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CATECHOLAMINE; GLUCOSE; HYDROCORTISONE; INSULIN; INTERLEUKIN 10; INTERLEUKIN 6; KALLIKREIN; LIPOPOLYSACCHARIDE BINDING PROTEIN; MACROPHAGE MIGRATION INHIBITION FACTOR; OROSOMUCOID; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA; URIC ACID; UROCORTIN I; UROCORTIN III; VASCULOTROPIN;

APNEA HYPOPNEA INDEX; APNEA INDEX; DIAGNOSTIC VALUE; DISEASE SEVERITY; HUMAN; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; REVIEW; SENSITIVITY AND SPECIFICITY; SLEEP DISORDERED BREATHING; SNORING; ADULT; BLOOD; CHILD; SLEEP APNEA, OBSTRUCTIVE; URINE;

ADULT; BIOMARKERS; CHILD; HUMANS; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE;

EID: 84926422041     PISSN: 10870792     EISSN: 15322955     Source Type: Journal    
DOI: 10.1016/j.smrv.2014.11.004     Document Type: Review

References (166)

1. Leger D., Bayon V., Laaban J.P., Philip P. Impact of sleep apnea on economics. Sleep Med Rev 2012, 16(5):455-462.
2. Tarasiuk A., Reuveni H. The economic impact of obstructive sleep apnea. Curr Opin Pulm Med 2013, 19(6):639-644.
3. Skaer T.L., Sclar D.A. Economic implications of sleep disorders. Pharmaco Econom 2010, 28(11):1015-1023.
4. Hillman D.R., M A., Pezzullo L. The economic cost of sleep disorders. Sleep 2006, 29:299-305.
5. Yamagishi K., Ohira T., Nakano H., Bielinski S.J., Sakurai S., Imano H., et al. Cross-cultural comparison of the sleep-disordered breathing prevalence among Americans and Japanese. Eur Respir J 2010, 36(2):379-384.
6. Ralls F.M., Grigg-Damberger M. Roles of gender, age, race/ethnicity, and residential socioeconomics in obstructive sleep apnea syndromes. Curr Opin Pulm Med 2012, 18(6):568-573.
7. Mirrakhimov A.E., T S., Erkin M., Mirrakhimov E.M. Prevalence of obstructive sleep apnea in Asian adults: a systematic review of the literature. BMC Pulm Med 2013, 13:1-10.
8. Buxbaum S.G., Elston R.C., Tishler P.V., Redline S. Genetics of the apnea hypopnea index in Caucasians and African Americans: I. Segregation analysis. Genet Epidemiol 2002, 22(3):243-253.
9. Lumeng J.C., Chervin R.D. Epidemiology of pediatric obstructive sleep apnea. Proc Am Thorac Soc 2008, 5(2):242-252.
10. B E.O. Sleep disordered breathing in children in a general population sample: prevalence and risk factors. Sleep 2009, 32(6):731-736.
11. Marcus C.L., Brooks L.J., Draper K.A., Gozal D., Halbower A.C., Jones J., et al. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics 2012, 130(3):576-584.
12. Gozal D. Serum, urine, and breath-related biomarkers in the diagnosis of obstructive sleep apnea in children: is it for real?. Curr Opin Pulm Med 2012, 18(6):561-567.
13. Shih J.L., Malhotra A. Could vitamins be helpful to patients with sleep apnea?. Chest 2011, 139(2):237-238.
14. Arksey H., OM L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol 2005, 8(1):19-32.
15. Bratel T., Wennlund A., Carlstrom K. Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea. Effects of continuous positive airway pressure treatment (CPAP). Respir Med 1999, 93(1):1-7.
16. Calvin A.D., Somers V.K., Steensma D.P., Rio Perez J.A., van der Walt C., Fitz-Gibbon J.M., et al. Advanced heart failure and nocturnal hypoxaemia due to central sleep apnoea are associated with increased serum erythropoietin. Eur J Heart Fail 2010, 12(4):354-359.
17. Cholidou K.G., Kostakis I.D., Manali E.D., Perrea D., Margeli A., Vougas K., et al. Calprotectin: a protein related to cardiovascular risk in adult patients with obstructive sleep apnea. Cytokine 2013, 61(3):917-923.
18. Culla B., Guida G., Brussino L., Tribolo A., Cicolin A., Sciascia S., et al. Increased oral nitric oxide in obstructive sleep apnoea. Respir Med 2010, 104(2):316-320.
19. El-Solh A.A., Mador M.J., Sikka P., Dhillon R.S., Amsterdam D., Grant B.J. Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea. Chest 2002, 121(5):1541-1547.
20. Gozal D., Crabtree V.M., Sans Capdevila O., Witcher L.A., Kheirandish-Gozal L. C-reactive protein, obstructive sleep apnea, and cognitive dysfunction in school-aged children. Am J Respir Crit Care Med 2007, 176(2):188-193.
21. Gozal D., Serpero L.D., Kheirandish-Gozal L., Capdevila O.S., Khalyfa A., Tauman R. Sleep measures and morning plasma TNF-alpha levels in children with sleep-disordered breathing. Sleep 2010, 33(3):319-325.
22. Khalyfa A., Gharib S.A., Kim J., Capdevila O.S., Kheirandish-Gozal L., Bhattacharjee R., et al. Peripheral blood leukocyte gene expression patterns and metabolic parameters in habitually snoring and non-snoring children with normal polysomnographic findings. Sleep 2011, 34(2):153-160.
23. Kim J., Bhattacharjee R., Khalyfa A., Kheirandish-Gozal L., Capdevila O.S., Wang Y., et al. DNA methylation in inflammatory genes among children with obstructive sleep apnea. Am J Respir Crit care Med 2012, 185(3):330-338.
24. Kishida K., Funahashi T., Shimomura I. Adiponectin as a routine clinical biomarker. Best Pract Res Clin Endocrinol Metab 2014, 28(1):119-130.
25. Lin Q.C., Xie H.S., Liu X.J., Zhou J.L., Zhao J.M. Relationship between obstructive sleep apnea-hypopnea syndrome and high sensitivity C-reactive protein in non-obese subjects. Zhonghua yi xue za zhi 2013, 93(30):2355-2358.
26. Loubaki L., Jacques E., Semlali A., Biardel S., Chakir J., Series F. Tumor necrosis factor-alpha expression in uvular tissues differs between snorers and apneic patients. Chest 2008, 134(5):911-918.
27. Makino S., Handa H., Suzukawa K., Fujiwara M., Nakamura M., Muraoka S., et al. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin Endocrinol 2006, 64(1):12-19.
28. Osorio R.S., Ayappa I., Mantua J., Gumb T., Varga A., Mooney A.M., et al. The interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals. Neurobiol Aging 2014, 35(6):1318-1324.
29. Oyama J., Yamamoto H., Maeda T., Ito A., Node K., Makino N. Continuous positive airway pressure therapy improves vascular dysfunction and decreases oxidative stress in patients with the metabolic syndrome and obstructive sleep apnea syndrome. Clin Cardiol 2012, 35(4):231-236.
30. Patel S.R., Zhu X., Storfer-Isser A., Mehra R., Jenny N.S., Tracy R., et al. Sleep duration and biomarkers of inflammation. Sleep 2009, 32(2):200-204.
31. Przybylowski T., Bielicki P., Kumor M., Hildebrand K., Maskey-Warzechowska M., Fangrat A., et al. Exhaled nitric oxide in patients with obstructive sleep apnea syndrome. Pneumonol i alergol pol 2006, 74(1):21-25.
32. Roche F., Gaspoz J.M., Pichot V., Picard-Kossovsky M., Maudoux D., Garcin A., et al. Association between C-reactive protein and unrecognised sleep-disordered breathing in the elderly. Eur Respir J 2009, 33(4):797-803.
33. Rubinsztajn R., Kumor M., Byskiniewicz K., Chazan R. The influence of 3 weeks therapy with continuous positive airway pressure on serum leptin and homocysteine concentration in patients with obstructive sleep apnea syndrome. Pneumonol i alergol pol 2006, 74(1):63-67.
34. Salord N., Gasa M., Mayos M., Fortuna-Gutierrez A.M., Montserrat J.M., Sanchez-de-la-Torre M., et al. Impact of OSA on biological markers in morbid obesity and metabolic syndrome. J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med 2014, 10(3):263-270.
35. Staats R., Stoll P., Zingler D., Virchow J.C., Lommatzsch M. Regulation of brain-derived neurotrophic factor (BDNF) during sleep apnoea treatment. Thorax 2005, 60(8):688-692.
36. Uysal A., Liendo C., McCarty D.E., Kim P.Y., Paxson C., Chesson A.L., et al. Nocturnal hypoxemia biomarker predicts sleepiness in patients with severe obstructive sleep apnea. Sleep Breath = Schlaf Atmung 2014, 18(1):77-84.
37. Van Hoorenbeeck K., Franckx H., Debode P., Aerts P., Wouters K., Ramet J., et al. Weight loss and sleep-disordered breathing in childhood obesity: effects on inflammation and uric acid. Obesity 2012, 20(1):172-177.
38. Wang Y.N., Yang Y., Luo Y.Q., Chen L.L. Effects of nasal continuous positive airway pressure short-term treatment on C-reactive protein and intercellular adhesion molecule-1 in patients with obstructive sleep apnea-hypopnea syndrome. Zhong nan da xue xue bao Yi xue ban = J Central South Univ Med Sci 2005, 30(6):666-669.
39. Wang Y., Wang J.J., Zhao M.Q., Liu S.M., Li Y.Z. Changes of serum brain-derived neurotrophic factor in children with obstructive sleep apnoea-hypopnoea syndrome following adenotonsillectomy. J Int Med Res 2010, 38(6):1942-1951.
40. Wang W., Redline S., Khoo M.C. Autonomic markers of impaired glucose metabolism: effects of sleep-disordered breathing. J Diabetes Sci Technol 2012, 6(5):1159-1171.
41. Deboer M.D., Mendoza J.P., Liu L., Ford G., Yu P.L., Gaston B.M. Increased systemic inflammation overnight correlates with insulin resistance among children evaluated for obstructive sleep apnea. Sleep Breath = Schlaf Atmung 2012, 16(2):349-354.
42. Gozal D., Lipton A.J., Jones K.L. Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea. Sleep 2002, 25(1):59-65.
43. Tauman R., Ivanenko A., O'Brien L.M., Gozal D. Plasma C-reactive protein levels among children with sleep-disordered breathing. Pediatrics 2004, 113(6):e564-e569.
44. Larkin E.K., Rosen C.L., Kirchner H.L., Storfer-Isser A., Emancipator J.L., Johnson N.L., et al. Variation of C-reactive protein levels in adolescents: association with sleep-disordered breathing and sleep duration. Circulation 2005, 111(15):1978-1984.
45. Goldbart A.D., Krishna J., Li R.C., Serpero L.D., Gozal D. Inflammatory mediators in exhaled breath condensate of children with obstructive sleep apnea syndrome. Chest 2006, 130(1):143-148.
46. Kheirandish-Gozal L., Capdevila O.S., Tauman R., Gozal D. Plasma C-reactive protein in nonobese children with obstructive sleep apnea before and after adenotonsillectomy. J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med 2006, 2(3):301-304.
47. Krishna J., Shah Z.A., Merchant M., Klein J.B., Gozal D. Urinary protein expression patterns in children with sleep-disordered breathing: preliminary findings. Sleep Med 2006, 7(3):221-227.
48. Montgomery-Downs H.E., Krishna J., Roberts L.J., Gozal D. Urinary F2-isoprostane metabolite levels in children with sleep-disordered breathing. Sleep Breath = Schlaf Atmung 2006, 10(4):211-215.
49. O'Brien L.M., Serpero L.D., Tauman R., Gozal D. Plasma adhesion molecules in children with sleep-disordered breathing. Chest 2006, 129(4):947-953.
50. Shah Z.A., Jortani S.A., Tauman R., Valdes R., Gozal D. Serum proteomic patterns associated with sleep-disordered breathing in children. Pediatr Res 2006, 59(3):466-470.
51. Tauman R., Serpero L.D., Capdevila O.S., O'Brien L.M., Goldbart A.D., Kheirandish-Gozal L., et al. Adipokines in children with sleep disordered breathing. Sleep 2007, 30(4):443-449.
52. Gozal D., Serpero L.D., Sans Capdevila O., Kheirandish-Gozal L. Systemic inflammation in non-obese children with obstructive sleep apnea. Sleep Med 2008, 9(3):254-259.
53. Gozal D., Jortani S., Snow A.B., Kheirandish-Gozal L., Bhattacharjee R., Kim J., et al. Two-dimensional differential in-gel electrophoresis proteomic approaches reveal urine candidate biomarkers in pediatric obstructive sleep apnea. Am J Respir Crit Care Med 2009, 180(12):1253-1261.
54. Kim J., Bhattacharjee R., Snow A.B., Capdevila O.S., Kheirandish-Gozal L., Gozal D. Myeloid-related protein 8/14 levels in children with obstructive sleep apnoea. Eur Respir J 2010, 35(4):843-850.
55. Bhushan B., Khalyfa A., Spruyt K., Kheirandish-Gozal L., Capdevila O.S., Bhattacharjee R., et al. Fatty-acid binding protein 4 gene polymorphisms and plasma levels in children with obstructive sleep apnea. Sleep Med 2011, 12(7):666-671.
56. Khalyfa A., Kheirandish-Gozal L., Capdevila O.S., Bhattacharjee R., Gozal D. Macrophage migration inhibitory factor gene polymorphisms and plasma levels in children with obstructive sleep apnea. Pediatr Pulmonol 2012, 47(10):1001-1011.
57. Gozal D., Kheirandish-Gozal L., Bhattacharjee R., Molero-Ramirez H., Tan H.L., Bandla H.P. Circulating adropin concentrations in pediatric obstructive sleep apnea: potential relevance to endothelial function. J Pediatr 2013, 163(4):1122-1126.
58. Kheirandish-Gozal L., McManus C.J., Kellermann G.H., Samiei A., Gozal D. Urinary neurotransmitters are selectively altered in children with obstructive sleep apnea and predict cognitive morbidity. Chest 2013, 143(6):1576-1583.
59. Kim J., Gozal D., Bhattacharjee R., Kheirandish-Gozal L. TREM-1 and pentraxin-3 plasma levels and their association with obstructive sleep apnea, obesity, and endothelial function in children. Sleep 2013, 36(6):923-931.
60. Kheirandish-Gozal L., Peris E., Wang Y., Tamae Kakazu M., Khalyfa A., Carreras A., et al. Lipopolysaccharide-binding protein plasma levels in children: effects of obstructive sleep apnea and obesity. J Clin Endocrinol Metab 2014, 99(2):656-663.
61. Kaditis A.G., Alexopoulos E.I., Damani E., Karadonta I., Kostadima E., Tsolakidou A., et al. Obstructive sleep-disordered breathing and fasting insulin levels in nonobese children. Pediatr Pulmonol 2005, 40(6):515-523.
62. Kaditis A.G., Alexopoulos E.I., Kalampouka E., Hatzi F., Karadonta I., Kyropoulos T., et al. Nocturnal change of circulating intercellular adhesion molecule 1 levels in children with snoring. Sleep Breath = Schlaf Atmung 2007, 11(4):267-274.
63. Kaditis A.G., Alexopoulos E., Chaidas K., Ntamagka G., Karathanasi A., Tsilioni I., et al. Urine concentrations of cysteinyl leukotrienes in children with obstructive sleep-disordered breathing. Chest 2009, 135(6):1496-1501.
64. Kaditis A.G., Alexopoulos E.I., Damani E., Hatzi F., Chaidas K., Kostopoulou T., et al. Urine levels of catecholamines in Greek children with obstructive sleep-disordered breathing. Pediatr Pulmonol 2009, 44(1):38-45.
65. Malakasioti G., Alexopoulos E., Befani C., Tanou K., Varlami V., Ziogas D., et al. Oxidative stress and inflammatory markers in the exhaled breath condensate of children with OSA. Sleep Breath = Schlaf Atmung 2012, 16(3):703-708.
66. Li A.M., Chan M.H., Chan D.F., Lam H.S., Wong E.M., So H.K., et al. Insulin and obstructive sleep apnea in obese Chinese children. Pediatr Pulmonol 2006, 41(12):1175-1181.
67. Li A.M., Ng C., Ng S.K., Chan M.M., So H.K., Chan I., et al. Adipokines in children with obstructive sleep apnea and the effects of treatment. Chest 2010, 137(3):529-535.
68. Li A.M., Chan M.H., Yin J., So H.K., Ng S.K., Chan I.H., et al. C-reactive protein in children with obstructive sleep apnea and the effects of treatment. Pediatr Pulmonol 2008, 43(1):34-40.
69. Park C.S., Guilleminault C., Hwang S.H., Jeong J.H., Park D.S., Maeng J.H. Correlation of salivary cortisol level with obstructive sleep apnea syndrome in pediatric subjects. Sleep Med 2013, 14(10):978-984.
70. Jeong J.H., Guilleminault C., Park C.S., Son H.L., Lee H.K., Hwang S.H., et al. Changes in salivary cortisol levels in pediatric patients with obstructive sleep apnea syndrome after adenotonsillectomy. Sleep Med 2014 Jun, 15(6):672-676. 10.1016/j.sleep.2013.12.019.
71. Park C.S., Guilleminault C., Park H.J., Cho J.H., Lee H.K., Son H.L., et al. Correlation of salivary alpha amylase level and adenotonsillar hypertrophy with sleep disordered breathing in pediatric subjects. J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med 2014, 10(5):559-566.
72. Patacchioli F.R., Tabarrini A., Ghiciuc C.M., Dima-Cozma L.C., Prete A., Bianchini C., et al. Salivary biomarkers of obstructive sleep apnea syndrome in children. Pediatr Pulmonol 2014 Nov, 49(11):1145-1152. 10.1002/ppul.22972.
73. Villa M.P., Supino M.C., Fedeli S., Rabasco J., Vitelli O., Del Pozzo M., et al. Urinary concentration of 8-isoprostane as marker of severity of pediatric OSAS. Sleep Breath 2014 Dec, 18(4):723-729. 10.1007/s11325-013-0934-0.
74. Stefanini Dde O., Barros E.L., Stefanini R., Pradella-Hallinan M.L., Pignatari S.S., Fujita R.R. Comparing the clinical profile of non obese children with sleep apnea and snoring. Braz J Otorhinolaryngol 2012, 78(5):22-26.
75. Benedek P., Lazar Z., Bikov A., Kunos L., Katona G., Horvath I. Exhaled biomarker pattern is altered in children with obstructive sleep apnoea syndrome. Int J Pediatr Otorhinolaryngol 2013, 77(8):1244-1247.
76. Ye J., Liu H., Li Y., Liu X., Zhu J.M. Increased serum levels of C-reactive protein and matrix metalloproteinase-9 in obstructive sleep apnea syndrome. Chin Med J 2007, 120(17):1482-1486.
77. Lam J.C., Yan C.S., Lai A.Y., Tam S., Fong D.Y., Lam B., et al. Determinants of daytime blood pressure in relation to obstructive sleep apnea in men. Lung 2009, 187(5):291-298.
78. Li Y., Chongsuvivatwong V., Geater A., Liu A. Exhaled breath condensate cytokine level as a diagnostic tool for obstructive sleep apnea syndrome. Sleep Med 2009, 10(1):95-103.
79. Lui M.M., Lam J.C., Mak H.K., Xu A., Ooi C., Lam D.C., et al. C-reactive protein is associated with obstructive sleep apnea independent of visceral obesity. Chest 2009, 135(4):950-956.
80. Ye L., Ma G.H., Chen L., Li M., Liu J.L., Yang K., et al. Quantification of circulating cell-free DNA in the serum of patients with obstructive sleep apnea-hypopnea syndrome. Lung 2010, 188(6):469-474.
81. Feng X., Li P., Zhou C., Jia X., Kang J. Elevated levels of serum chemerin in patients with obstructive sleep apnea syndrome. Biomarkers Biochem Indic Expo Response Susceptibility Chem 2012, 17(3):248-253.
82. Guo Q., Wang Y., Li Q.Y., Li M., Wan H.Y. Levels of thioredoxin are related to the severity of obstructive sleep apnea: based on oxidative stress concept. Sleep Breath = Schlaf Atmung 2013, 17(1):311-316.
83. Shi Y.K., Chen J.X., Huang Y., Li A.Y. Serum S100A12 levels are associated with the presence and severity of obstructive sleep apnea syndrome in male patients. Sleep Breath 2014 May, 18(2):269-274. 10.1007/s11325-013-0876-6.
84. Wang Q., Feng X., Zhou C., Li P., Kang J. Decreased levels of serum omentin-1 in patients with obstructive sleep apnoea syndrome. Ann Clin Biochem 2013, 50(Pt 3):230-235.
85. Wang Y., Li Y., Chen P., Luo Y., Yang Y., Yang Y. Elevated fractalkine in patients with obstructive sleep apnea hypopnea syndrome. Sleep Breath = Schlaf Atmung 2013, 17(1):203-208.
86. Zhang X.B., Lin Q.C., Deng C.S., Chen G.P., Cai Z.M., Chen H. Elevated serum cystatin C in severe OSA younger men without complications. Sleep Breath = Schlaf Atmung 2013, 17(1):235-241.
87. Wang X., Xing G.H. Serum YKL-40 concentrations are elevated and correlated with disease severity in patients with obstructive sleep apnea syndrome. Scand J Clin Lab Invest 2014, 74(1):74-78.
88. Shamsuzzaman A.S.M. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002, 105(21):2462-2464.
89. Guilleminault C., Kirisoglu C., Ohayon M.M. C-reactive protein and sleep-disordered breathing. Sleep 2004, 27(8):1507-1511.
90. Htoo A.K., Greenberg H., Tongia S., Chen G., Henderson T., Wilson D., et al. Activation of nuclear factor kappaB in obstructive sleep apnea: a pathway leading to systemic inflammation. Sleep Breath = Schlaf Atmung 2006, 10(1):43-50.
91. Mehra R., Storfer-Isser A., Kirchner H.L., Johnson N., Jenny N., Tracy R.P., et al. Soluble interleukin 6 receptor: a novel marker of moderate to severe sleep-related breathing disorder. Archives Intern Med 2006, 166(16):1725-1731.
92. Punjabi N.M., Beamer B.A. C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep 2007, 30(1):29-34.
93. Norman D., Bardwell W.A., Arosemena F., Nelesen R., Mills P.J., Loredo J.S., et al. Serum aminotransferase levels are associated with markers of hypoxia in patients with obstructive sleep apnea. Sleep 2008, 31(1):121-126.
94. Lederer D.J., Jelic S., Basner R.C., Ishizaka A., Bhattacharya J. Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnoea. Eur Respir J 2009, 33(4):793-796.
95. Pallayova M., Steele K.E., Magnuson T.H., Schweitzer M.A., Hill N.R., Bevans-Fonti S., et al. Sleep apnea predicts distinct alterations in glucose homeostasis and biomarkers in obese adults with normal and impaired glucose metabolism. Cardiovasc Diabetol 2010, 9:83.
96. Akinnusi M.E., Laporta R., El-Solh A.A. Lectin-like oxidized low-density lipoprotein receptor-1 modulates endothelial apoptosis in obstructive sleep apnea. Chest 2011, 140(6):1503-1510.
97. Ladesich J.B., Pottala J.V., Romaker A., Harris W.S. Membrane level of omega-3 docosahexaenoic acid is associated with severity of obstructive sleep apnea. J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med 2011, 7(4):391-396.
98. Pallayova M., Steele K.E., Magnuson T.H., Schweitzer M.A., Smith P.L., Patil S.P., et al. Sleep apnea determines soluble TNF-alpha receptor 2 response to massive weight loss. Obes Surg 2011, 21(9):1413-1423.
99. Chin K., Nakamura T., Shimizu K., Mishima M., Nakamura T., Miyasaka M., et al. Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 2000, 109(7):562-567.
100. Ohga E., Tomita T., Wada H., Yamamoto H., Nagase T., Ouchi Y. Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 2003, 94(1):179-184.
101. Yokoe T. Elevated levels of C-reactive protein and Interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003, 107(8):1129-1134.
102. Imagawa S., Yamaguchi Y., Ogawa K., Obara N., Suzuki N., Yamamoto M., et al. Interleukin-6 and tumor necrosis factor-alpha in patients with obstructive sleep apnea-hypopnea syndrome. Respir Int Rev Thorac Dis 2004, 71(1):24-29.
103. Sukegawa M., Noda A., Sugiura T., Nakata S., Yoshizaki S., Soga T., et al. Assessment of continuous positive airway pressure treatment in obstructive sleep apnea syndrome using 24-hour urinary catecholamines. Clin Cardiol 2005, 28(11):519-522.
104. Yamauchi M., Nakano H., Maekawa J., Okamoto Y., Ohnishi Y., Suzuki T., et al. Oxidative stress in obstructive sleep apnea. Chest 2005, 127(5):1674-1679.
105. Burioka N., Miyata M., Fukuoka Y., Endo M., Shimizu E. Day-night variations of serum interleukin-6 in patients with severe obstructive sleep apnea syndrome before and after continuous positive airway pressure (CPAP). Chronobiol Int 2008, 25(5):827-834.
106. Takahashi K., Chin K., Nakamura H., Morita S., Sumi K., Oga T., et al. Plasma thioredoxin, a novel oxidative stress marker, in patients with obstructive sleep apnea before and after nasal continuous positive airway pressure. Antioxid Redox SignalArch Intern Med 2008, 10(4):715-726.
107. Kuramoto E., Kinami S., Ishida Y., Shiotani H., Nishimura Y. Continuous positive nasal airway pressure decreases levels of serum amyloid A and improves autonomic function in obstructive sleep apnea syndrome. Int J Cardiol 2009, 135(3):338-345.
108. Aihara K., Oga T., Chihara Y., Harada Y., Tanizawa K., Handa T., et al. Analysis of systemic and airway inflammation in obstructive sleep apnea. Sleep Breath = Schlaf Atmung 2013, 17(2):597-604.
109. Murase K., Mori K., Yoshimura C., Aihara K., Chihara Y., Azuma M., et al. Association between plasma neutrophil gelatinase associated lipocalin level and obstructive sleep apnea or nocturnal intermittent hypoxia. PLoS One 2013, 8(1):e54184.
110. Lavie L., Kraiczi H., Hefetz A., Ghandour H., Perelman A., Hedner J., et al. Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment. Am J Respir Crit Care Med 2002, 165(12):1624-1628.
111. Ting H., Lo H.S., Chang S.Y., Chung A.H., Kuan P.C., Yuan S.C., et al. Post- to pre-overnight sleep systolic blood pressures are associated with sleep respiratory disturbance, pro-inflammatory state and metabolic situation in patients with sleep-disordered breathing. Sleep Med 2009, 10(7):720-725.
112. Papaioannou I., Twigg G.L., Kemp M., Roughton M., Hooper J., Morrell M.J., et al. Melatonin concentration as a marker of the circadian phase in patients with obstructive sleep apnoea. Sleep Med 2012, 13(2):167-171.
113. Christou K., Moulas A.N., Pastaka C., Gourgoulianis K.I. Antioxidant capacity in obstructive sleep apnea patients. Sleep Med 2003, 4(3):225-228.
114. Schulz R., Hummel C., Heinemann S., Seeger W., Grimminger F. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit care Med 2002, 165(1):67-70.
115. Alzoghaibi M.A., Bahammam A.S. Lipid peroxides, superoxide dismutase and circulating IL-8 and GCP-2 in patients with severe obstructive sleep apnea: a pilot study. Sleep Breath = Schlaf Atmung 2005, 9(3):119-126.
116. Braga C.W., Martinez D., Wofchuk S., Portela L.V., Souza D.O. S100B and NSE serum levels in obstructive sleep apnea syndrome. Sleep Med 2006, 7(5):431-435.
117. Lentini S., Manka R., Scholtyssek S., Stoffel-Wagner B., Luderitz B., Tasci S. Creatine phosphokinase elevation in obstructive sleep apnea syndrome: an unknown association?. Chest 2006, 129(1):88-94.
118. Peled N., Shitrit D., Bendayan D., Peled E., Kramer M.R. Association of elevated levels of vascular endothelial growth factor in obstructive sleep apnea syndrome with patient age rather than with obstructive sleep apnea syndrome severity. Respir Int Rev Thorac Dis 2007, 74(1):50-55.
119. Ryan S., Nolan G.M., Hannigan E., Cunningham S., Taylor C., McNicholas W.T. Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax 2007, 62(6):509-514.
120. Ursavas A., Karadag M., Rodoplu E., Yilmaztepe A., Oral H.B., Gozu R.O. Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome. Respir Int Rev Thorac Dis 2007, 74(5):525-532.
121. Constantinidis J., Ereliadis S., Angouridakis N., Konstantinidis I., Vital V., Angouridaki C. Cytokine changes after surgical treatment of obstructive sleep apnoea syndrome. Eur Arch Oto-rhino-laryngology Off J Eur Fed Oto-Rhino-Laryngol Soc 2008, 265(10):1275-1279.
122. Kanbay A., Kokturk O., Ciftci T.U., Tavil Y., Bukan N. Comparison of serum adiponectin and tumor necrosis factor-alpha levels between patients with and without obstructive sleep apnea syndrome. Respir Int Rev Thorac Dis 2008, 76(3):324-330.
123. Zamarron C., Ricoy J., Riveiro A., Gude F. Plasminogen activator inhibitor-1 in obstructive sleep apnea patients with and without hypertension. Lung 2008, 186(3):151-156.
124. Kim J., Lee S., In K., Kim J., You S., Kang K., et al. Increase in serum haptoglobin and apolipoprotein M in patients with obstructive sleep apnoea. J Sleep Res 2009, 18(3):313-320.
125. Ucar Z.Z., Taymaz Z., Erbaycu A.E., Kirakli C., Tuksavul F., Guclu S.Z. Nocturnal hypoxia and arterial lactate levels in sleep-related breathing disorders. South Med J 2009, 102(7):693-700.
126. Lee L.A., Chen N.H., Huang C.G., Lin S.W., Fang T.J., Li H.Y. Patients with severe obstructive sleep apnea syndrome and elevated high-sensitivity C-reactive protein need priority treatment. Otolaryngol-head neck Surg Off J Am Acad Otolaryngol-Head Neck Surg 2010, 143(1):72-77.
127. Steiropoulos P., Papanas N., Nena E., Antoniadou M., Serasli E., Papoti S., et al. Inflammatory markers in middle-aged obese subjects: does obstructive sleep apnea syndrome play a role?. Mediat Inflamm 2010, 2010. 675320.
128. Cintra F., Tufik S., D'Almeida V., Calegare B.F., de Paola A., Oliveira W., et al. Cysteine: a potential biomarker for obstructive sleep apnea. Chest 2011, 139(2):246-252.
129. Hira H.S., Shukla A., Kaur A., Kapoor S. Serum uric acid and lactate levels among patients with obstructive sleep apnea syndrome: which is a better marker of hypoxemia?. Ann Saudi Med 2012, 32(1):37-42.
130. Jurado-Gamez B., Fernandez-Marin M.C., Gomez-Chaparro J.L., Munoz-Cabrera L., Lopez-Barea J., Perez-Jimenez F., et al. Relationship of oxidative stress and endothelial dysfunction in sleep apnoea. Eur Respir J 2011, 37(4):873-879.
131. Svensson M., Venge P., Janson C., Lindberg E. Relationship between sleep-disordered breathing and markers of systemic inflammation in women from the general population. J Sleep Res 2012, 21(2):147-154.
132. Zamarron C., Riveiro A., Gude F. Circulating levels of vascular endothelial markers in obstructive sleep apnoea syndrome. Effects of nasal continuous positive airway pressure. Arch Med Sci AMS 2011, 7(6):1023-1028.
133. Duru S., Hikmet Firat I., Colak N., Ginis Z., Delibasi T., Ardic S. Serum S100B protein: a useful marker in obstructive sleep apnea syndrome. Neurol i Neurochir pol 2012, 46(5):450-455.
134. Guven S.F., Turkkani M.H., Ciftci B., Ciftci T.U., Erdogan Y. The relationship between high-sensitivity C-reactive protein levels and the severity of obstructive sleep apnea. Sleep Breath = Schlaf Atmung 2012, 16(1):217-221.
135. Jurado-Gamez B., Cabrera C.B., Ballesteros L.C., Hinojosa C.M., Cabrera L.M., Perez-Jimenez F., et al. Association of cellular adhesion molecules and oxidative stress with endothelial function in obstructive sleep apnea. Intern Med 2012, 51(4):363-368.
136. Lee S.D., Ju G., Choi J.A., Kim J.W., Yoon I.Y. The association of oxidative stress with central obesity in obstructive sleep apnea. Sleep Breath = Schlaf Atmung 2012, 16(2):511-517.
137. Mancuso M., Bonanni E., LoGerfo A., Orsucci D., Maestri M., Chico L., et al. Oxidative stress biomarkers in patients with untreated obstructive sleep apnea syndrome. Sleep Med 2012, 13(6):632-636.
138. Simiakakis M., Kapsimalis F., Chaligiannis E., Loukides S., Sitaras N., Alchanatis M. Lack of effect of sleep apnea on oxidative stress in obstructive sleep apnea syndrome (OSAS) patients. PLoS One 2012, 7(6):e39172.
139. Sokucu S.N., Karasulu L., Dalar L., Seyhan E.C., Altin S. Can red blood cell distribution width predict severity of obstructive sleep apnea syndrome?. J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med 2012, 8(5):521-525.
140. Chung F., Chau E., Yang Y., Liao P., Hall R., Mokhlesi B. Serum bicarbonate level improves specificity of STOP-Bang screening for obstructive sleep apnea. Chest 2013, 143(5):1284-1293.
141. Cofta S., Wysocka E., Dziegielewska-Gesiak S., Michalak S., Piorunek T., Batura-Gabryel H., et al. Plasma selectins in patients with obstructive sleep apnea. Adv Exp Med Biol 2013, 756:113-119.
142. Ferrarini A., Ruperez F.J., Erazo M., Martinez M.P., Villar-Alvarez F., Peces-Barba G., et al. Fingerprinting-based metabolomic approach with LC-MS to sleep apnea and hypopnea syndrome: a pilot study. Electrophoresis 2013, 34(19):2873-2881.
143. Hirotsu C., Tufik S., Guindalini C., Mazzotti D.R., Bittencourt L.R., Andersen M.L. Association between uric acid levels and obstructive sleep apnea syndrome in a large epidemiological sample. PLoS One 2013, 8(6):e66891.
144. Kurt O.K., Yildiz N. The importance of laboratory parameters in patients with obstructive sleep apnea syndrome. Blood Coagulation Fibrinolysis Int J Haemostasis Thrombosis 2013, 24(4):371-374.
145. Ntalapascha M., Makris D., Kyparos A., Tsilioni I., Kostikas K., Gourgoulianis K., et al. Oxidative stress in patients with obstructive sleep apnea syndrome. Sleep Breath = Schlaf Atmung 2013, 17(2):549-555.
146. Ozben S., Guvenc T.S., Huseyinoglu N., Sanivar H.S., Hanikoglu F., Cort A., et al. Low serum copeptin levels in patients with obstructive sleep apnea. Sleep Breath = Schlaf Atmung 2013, 17(4):1187-1192.
147. Tual-Chalot S., Gagnadoux F., Trzepizur W., Priou P., Andriantsitohaina R., Martinez M.C. Circulating microparticles from obstructive sleep apnea syndrome patients induce endothelin-mediated angiogenesis. Biochim Biophys Acta 2014, 1842(2):202-207.
148. Vavougios G., Pastaka C., Tsilioni I., Natsios G., Seitanidis G., Florou E., et al. The DJ-1 protein as a candidate biomarker in obstructive sleep apnea syndrome. Sleep Breath 2014 Dec, 18(4):897-900. 10.1007/s11325-014-0952-6.
149. Carpagnano G.E., Kharitonov S.A., Resta O., Foschino-Barbaro M.P., Gramiccioni E., Barnes P.J. Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients. Chest 2002, 122(4):1162-1167.
150. Petrosyan M., Perraki E., Simoes D., Koutsourelakis I., Vagiakis E., Roussos C., et al. Exhaled breath markers in patients with obstructive sleep apnoea. Sleep Breath = Schlaf Atmung 2008, 12(3):207-215.
151. Phillips C.L., Yang Q., Williams A., Roth M., Yee B.J., Hedner J.A., et al. The effect of short-term withdrawal from continuous positive airway pressure therapy on sympathetic activity and markers of vascular inflammation in subjects with obstructive sleep apnoea. J Sleep Res 2007, 16(2):217-225.
152. Arias M.A., Garcia-Rio F., Alonso-Fernandez A., Hernanz A., Hidalgo R., Martinez-Mateo V., et al. CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 in obstructive sleep apnoea. Eur Respir J 2008, 32(4):1009-1015.
153. Kohler M., Stoewhas A.C., Ayers L., Senn O., Bloch K.E., Russi E.W., et al. Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med 2011, 184(10):1192-1199.
154. Pinto P., Barbara C., Montserrat J.M., Patarrao R.S., Guarino M.P., Carmo M.M., et al. Effects of CPAP on nitrate and norepinephrine levels in severe and mild-moderate sleep apnea. BMC Pulm Med 2013, 13:13.
155. Carpagnano G.E., Kharitonov S.A., Resta O., Foschino-Barbaro M.P., Gramiccioni E., Barnes P.J. 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 2003, 124(4):1386-1392.
156. Antonopoulou S., Loukides S., Papatheodorou G., Roussos C., Alchanatis M. Airway inflammation in obstructive sleep apnea: is leptin the missing link?. Respir Med 2008, 102(10):1399-1405.
157. Li Y., Chongsuvivatwong V., Geater A., Liu A. Are biomarker levels a good follow-up tool for evaluating obstructive sleep apnea syndrome treatments?. Respir Int Rev Thorac Dis 2008, 76(3):317-323.
158. Brockmann P.E., Schaefer C., Poets A., Poets C.F., Urschitz M.S. Diagnosis of obstructive sleep apnea in children: a systematic review. Sleep Med Rev 2013, 17(5):331-340.
159. Wong T.K. The search on an ideal disease marker for childhood obstructive sleep apnea syndrome. Sleep 2011, 34(2):133-134.
160. Gozal D., Kheirandish-Gozal L. New approaches to the diagnosis of sleep-disordered breathing in children. Sleep Med 2010, 11(7):708-713.
161. Nerfeldt P., Aoki F., Friberg D. Polygraphy vs. polysomnography: missing osas in symptomatic snorers-a reminder for clinicians. Sleep Breath = Schlaf Atmung 2014, 18(2):297-303.
162. Parati G., Lombardi C., Hedner J., Bonsignore M.R., Grote L., Tkacova R., et al. Recommendations for the management of patients with obstructive sleep apnoea and hypertension. Eur Respir J 2013, 41(3):523-538.
163. Grigg-Damberger M.M. The AASM scoring manual four years later. J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med 2012, 8(3):323-332.
164. Balk E.M., Moorthy D., Obadan N.O., Patel K., Ip S., Chung M., et al. Diagnosis and treatment of obstructive sleep apnea in adults. AHRQ comparative effectiveness reviews 2011, Rockville (MD).
165. Collop N.A., Anderson W.M., Boehlecke B., Claman D., Goldberg R., Gottlieb D.J., et al. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable monitoring task force of the American Academy of Sleep Medicine. J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med 2007, 3(7):737-747.
166. Health Quality O. Polysomnography in patients with obstructive sleep apnea: an evidence-based analysis. Ont Health Technol Assess Ser 2006, 6(13):1-38.